Overview

Treating Negative Affect in Low Back Pain Patients

Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This study will examine how the use of antidepressant, physical therapy, and combination of both affects pain, function, and depression outcomes in chronic low back pain patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ajay Wasan, MD, Msc
Collaborators:
Brigham and Women's Hospital
Mayo Clinic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health (NIH)
Treatments:
Antidepressive Agents
Aripiprazole
Bupropion
Citalopram
Duloxetine Hydrochloride
Mirtazapine
Sertraline
Venlafaxine Hydrochloride